Clinical Trials Logo

Filter by:
NCT ID: NCT03577210 Recruiting - Chin Microgenia Clinical Trials

The Degree of Accuracy of Patient-specific PEEK Implant to Restore Chin Deficiency

Start date: September 2018
Phase: N/A
Study type: Interventional

computer guided patient-specific PEEK implant will be used to augment patients with chin deficiency or chin asymmetry.

NCT ID: NCT03573102 Recruiting - Clinical trials for Diabetic Nephropathies

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Start date: June 20, 2018
Phase: Phase 4
Study type: Interventional

Diabetes Mellitus is the leading cause of end stage renal disease. As proven by many studies , controlling proteinuria can delay the progression to end stage renal disease.This work will study the effect of sodium glucose co transporter 2 inhibitor , a new antihyperglycemic drug , on proteinuria and to compare its effect with the effect of classic antiproteinuric drugs as angiotensin converting enzyme inhibitor , aspirin and statins.

NCT ID: NCT03566329 Recruiting - Hypertension Clinical Trials

Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension

Start date: July 10, 2018
Phase: Phase 1
Study type: Interventional

Post-craniotomy emergence hypertension is a common phenomenon that may predispose to development of intracranial hematoma and cerebral edema.The aim of this study is to compare the safety and efficacy of Mgso4 versus lidocaine infusion for control of emergence hypertension after craniotomy.

NCT ID: NCT03563534 Recruiting - Deep Caries Clinical Trials

Treatment of Primary Molars With Deep Caries Using Silver Diamine Fluoride

Start date: September 15, 2017
Phase: Phase 4
Study type: Interventional

Untreated dental caries is a worldwide pandemic (Edelstein, 2006). Due to limited financial resources, poor access to basic oral care, and the high cost of restorative treatment, children of low-income nations have their general health, social well-being, and education opportunities affected by untreated dental caries (Baelum et al., 2007). Traditional treatment of cavitated dentin lesions advocates complete removal of the decayed structure, i.e. the infected and affected dentin layers. During this procedure, however, a significant quantity of the dental structure is removed, and the pulp tissue may be exposed. In light of this, the complete removal of all decayed structures from a tooth with cavitated lesions is no longer seen as mandatory, as this increases the chance of pulp exposure, post-operative pain and weakens the tooth structure, and there is growing evidence to support incomplete removal of decayed tissue prior to the restoration of the cavity. It is argued, however, that carious lesions remaining in the cavity must be completely sealed in order to prevent their progression (Yee et al., 2009). Arresting Caries Treatment (ACT) has been proposed to oversee untreated dental caries in children of disadvantaged communities. Treatment of carious lesions based on minimally invasive technique methods aim to prevent their progression and preserve pulp vitality by means of standards of anticipation, remineralization and minimal intervention in the dental tissue (Bedi and Sardo-Infirri, 1999).

NCT ID: NCT03563508 Recruiting - Clinical trials for Morphology of Maxillary Premolars in Egyptian Subpopulation

A Cone-beam Computed Tomography Study of Root and Root Canal Morphology of Maxillary Premolars in an Egyptian Subpopulation

Start date: July 2018
Phase:
Study type: Observational

to date there is no detailed examination of the root and root canal system of maxillary first and second premolars in an Egyptian subpopulation. in this study the investigators do an Observational analysis of available records of cone-beam computed tomography (CBCT) of root and canal morphology in the permanent maxillary first and second premolars in this population

NCT ID: NCT03562598 Recruiting - High Risk Pregnancy Clinical Trials

Frequency of Performing Umbilical Artery Doppler in the Third Trimester in High Risk Pregnancy

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The aim of the current study was to produce a high quality evidence on the best frequency of performing umbilical artery Doppler for high risk pregnant women in the third trimester.

NCT ID: NCT03561285 Recruiting - Clinical trials for Stroke in Young Adults

Antiphospholipid Antibodies & Osteopontin as Risk Factors for Cerebrovascular Stroke in Young Adults

Start date: September 1, 2020
Phase:
Study type: Observational

The burden of stroke is increasing in many low- and middle income countries.(1) Around 10% of all thrombotic cerebrovascular events (CVE) occur in young population defined as younger than 50 years old (2) In the majority of these patients, the cause of the ischaemic stroke remains undetermined.(3) Arterial thrombosis is a major clinical manifestation of the antiphospholipid syndrome (APS), an autoimmune condition characterised by thrombotic events and/or pregnancy morbidity with persistently positive antiphospholipid antibodies (aPL) (4). Considering all patients with cerebral ischaemia, the prevalence of aPL seems rather high in young adults, who might constitute a subgroup at high risk for recurrence.(5) Through the support of the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION), a systematic review aiming to estimate the frequency of clinically significant aPL profiles in the general population (no age limit) was completed. (6) The pathogenesis of ischemic stroke is complex, and several studies documented hypercoagulable states as a significant mechanism underlying stroke. (8). The latter include protein C, protein S, or antithrombin III deficiencies, activated protein C resistance and anti-phospholipid antibodies (aPLA), including anticardiolipin (aCL) antibodies or lupus anticoagulant (LAC), which influence stroke susceptibility owing to their capacity to disturb normal hemostatic mechanisms (9). While aPLA are clinically associated with a state of hypercoagulation and prothrombotic disorders, the exact mechanism underlying their prothrombotic effects remains unknown (10). aPLA are detected either functionally, owing to their ability to prolong coagulation time in a phospholipid-dependent coagulation test (LAC), or by measuring specific [anticardiolipin (aCL) and antiphosphatidylserine (aPS)] antibodies by specific immunoassays, using anionic phospholipids as antigens (11). The contribution of LAC to the overall risk of both venous and arterial thrombosis, including ischemic stroke, is now well recognized (12). While the contribution of aPLA (including LAC and aCL antibodies) to thrombosis is well established, their role as independent risk factors in the pathogenesis of ischemic stroke yielded apparently conflicting results. (13). These conflicting results could be explained by differences in ethnic origin , inherent variation in aPLA levels and in the failure in some studies to account for the contribution of covariates (14). Osteopontin (OPN) was first identified as a protein involved in bone remodelling, but later also shown to have important immunological roles. (15).

NCT ID: NCT03560674 Recruiting - Traumatic Injury Clinical Trials

Evaluation of Intern Dentists in Emergency Management of Traumatic Dental Injuries in Primary Anterior Teeth

Start date: April 1, 2018
Phase:
Study type: Observational

This study aim to evaluate knowledge, attitude, and practice of intern dentistry in emergency management of traumatic dental injures in primary anterior teeth in children aged from 3-5 years old. Questionnaire survey will be designed to evaluate Knowledge - Attitude - and practice of intern dentists who met the eligibility criteria

NCT ID: NCT03552640 Recruiting - Clinical trials for Orthodontic Appliance Complication

Accuracy of Digital Three-Dimensional Root Position Prediction Via Digitized Models

Start date: August 2018
Phase:
Study type: Observational

Measuring the accuracy of a new technique by which root positions can be predicted at the pre-finishing stage of the comprehensive orthoodntic treatment

NCT ID: NCT03551444 Recruiting - Clinical trials for Hepatocellular Carcinoma

Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial

CAUTIOUS
Start date: October 1, 2017
Phase: Phase 3
Study type: Interventional

- Unexpected results were published in 2016 showed increased aggressiveness and rates of HCC recurrence after curative treatment of HCC in HCV patients treated by DAAs achieving SVR. On the other hand, the retrospective analysis of ANRS study, did not observe an increased risk of HCC recurrence after DAAs treatment in patients who underwent curative HCC treatment. - Assess the recurrence rate of HCC in HCV infected patients with prior history of treated HCC who achieved rCR with and without administration of DAAs and assess the effect of its timing.